The Future Of Psychedelics: Medicalization, Microdosing, And The Mainstream
For this week’s podcast, we bring you inside the first Third Wave Node event in New York City for a conversation between Dr. Will Siu — trained by MAPS for MDMA-assisted psychotherapy — and The Third Wave’s Paul Austin about the medicalization of psychedelics.
Will is a practicing psychiatrist working with patients on a daily basis and a passionate advocate for integrating psychedelics into psychiatric treatment models; he’s also experienced his own mental health struggles and the all-too-familiar frustrations with the limits of the current medical paradigm. All of this gives him a unique perspective on the topic of medicalization.
If you find yourself thinking about the challenges we’ll need to collectively overcome to ensure proper use of these substances legally, and on a large scale, you’ll want to hear Will’s take.
- Will’s beliefs about the sources of “psychiatric illnesses” and the roles psychedelics can play in treating or curing them, informed by his experience working with psychedelics and his formal medical training
- Will’s view of ketamine as a legal psychedelic that can facilitate transpersonal experiences and how it can be used beyond its current applications
- How we’ll navigate underlying socioeconomic dynamics like race and cost in a world where professionals with specific training with these substances strive to meet the needs of a diverse patient population